Literature DB >> 30126624

Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods.

Giulio Camarlinghi1, Eva Maria Parisio1, Alberto Antonelli2, Maria Nardone1, Marco Coppi2, Tommaso Giani2, Romano Mattei1, Gian Maria Rossolini3.   

Abstract

Fosfomycin susceptibility testing with Sensititre, Vitek2, Etest, Mic Strip Test and disk diffusion methodologies was compared versus reference agar dilution method (AD) with 78 clinical isolates of KPC-producing Klebsiella pneumoniae. All methodologies showed a Categorical Agreement and Essential Agreement of ≤69% and ≤72%, respectively, revealing a very low concordance with AD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Agar dilution; CPE; CRE; Fosfomycin-resistance; KPC-KP

Mesh：

Substances：

Year:  2018        PMID： 30126624     DOI： 10.1016/j.diagmicrobio.2018.07.014

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  11 in total

1.  Use of Fosfomycin Etest To Determine In Vitro Susceptibility of Clinical Isolates of Enterobacterales Other than Escherichia coli, Nonfermenting Gram-Negative Bacilli, and Gram-Positive Cocci.

Authors:  James A Karlowsky; Melanie R Baxter; Alyssa R Golden; Heather J Adam; Andrew Walkty; Philippe R S Lagacé-Wiens; George G Zhanel
Journal:  J Clin Microbiol       Date:  2021-09-08       Impact factor: 5.948

2.  Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction.

Authors:  Matteo Rinaldi; Pier Giorgio Cojutti; Eleonora Zamparini; Sara Tedeschi; Nicolò Rossi; Matteo Conti; Maddalena Giannella; Federico Pea; Pierluigi Viale
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191

3.  Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods.

Authors:  James A Karlowsky; Philippe R S Lagacé-Wiens; Nancy M Laing; Melanie R Baxter; Heather J Adam; George G Zhanel
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

4.  The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates.

Authors:  Zachary S Elliott; Katie E Barry; Heather L Cox; Nicole Stoesser; Joanne Carroll; Kasi Vegesana; Shireen Kotay; Anna E Sheppard; Alex Wailan; Derrick W Crook; Hardik Parikh; Amy J Mathers
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

5.  Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections.

Authors:  Yohei Doi
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

6.  Population structure of KPC carbapenemase-producing Klebsiella pneumoniae in a long-term acute-care rehabilitation facility: identification of a new lineage of clonal group 101, associated with local hyperendemicity.

Authors:  Fabio Arena; Vincenzo Di Pilato; Federica Vannetti; Laura Fabbri; Alberto Antonelli; Marco Coppi; Roberto Pupillo; Claudio Macchi; Gian Maria Rossolini
Journal:  Microb Genom       Date:  2020-01

Review 7.  Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.

Authors:  Xing Tan; Hwan Seung Kim; Kimberly Baugh; Yanqin Huang; Neeraja Kadiyala; Marisol Wences; Nidhi Singh; Eric Wenzler; Zackery P Bulman
Journal:  Infect Drug Resist       Date:  2021-01-18       Impact factor: 4.003

8.  Droplets generated from toilets during urination as a possible vehicle of carbapenem-resistant Klebsiella pneumoniae.

Authors:  Fabio Arena; Anna Rita Daniela Coda; Valentina Meschini; Roberto Verzicco; Arcangelo Liso
Journal:  Antimicrob Resist Infect Control       Date:  2021-10-20       Impact factor: 4.887

9.  Fosfomycin Susceptibility Testing Using Commercial Agar Dilution Test.

Authors:  Peter D Croughs; Michelle Konijnendijk-de Regt; Erlangga Yusuf
Journal:  Microbiol Spectr       Date:  2022-03-30

Review 10.  How to manage KPC infections.

Authors:  Matteo Bassetti; Maddalena Peghin
Journal:  Ther Adv Infect Dis       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.